CHEMICAL HYDROLYSIS, INSILICO PHYSICOCHEMICAL PROPERTIES AND IN-VIVO PHARMACOLOGICAL EVALUATION OF ANTIDIABTIC AND ANTIHYPERTENSIVE CODRUGS

Authors

  • Ganesh Sakharam Andhale Dept. of Pharmaceutical Chemistry, Acharya & B M Reddy College of Pharmacy, Bangalore

DOI:

https://doi.org/10.22270/ajprd.v6i6.452

Keywords:

propranolol, metoprolol, chemical hydrolysis, metformin, codrugs, antihypertensive, antidiabetic

Abstract

In the present research work codrugs of Propranolol and Metoprolol with Metformin were synthesized with an aim of improving the biological activity and to check the effectiveness of release of the parent drugs in presence of spacer. Ester prodrugs of Propranolol and metoprolol were synthesized by using succinic, maleic, pthalic anhydride and substituted derivatives of them. The resulted prodrugs were converted into codrugs (CO1-6) by reacting with Metformin. The compounds were characterized by melting point, FT-IR, 1H-NMR and mass spectroscopy. The chemical hydrolysis of CO1-6 was carried out at the pH 1.2, 6.8 and 7.4. Almost all compounds showed encouraging chemical stability at pH 1.2 and 6.8 whereas showed the moderate hydrolysis at pH 7.4 but codrug CO4 didn’t showed hydrolysis at any pH condition. Further codrugs were screened for antihypertensive and antidiabetic activity by simultaneous induction of two-kidney, one clip renal hypertension and STZ-induced diabetic model in wistar rats. The spacer containing dipropyl maleate codrugs (CO3 and CO6) showed longer duration of action. The current paper also describes about the molecular properties evaluation of  the synthesized codrugs.

Downloads

Download data is not yet available.

References

1. Black J. Reflections on drug research. Br J Pharmacol 2010; 161:1204-1216.
2. Akbar S, Alorainy MS. The current status of beta blockers’ use in the management of hypertension. Saudi Med J 2014; 35(11):1307-1317.
3. Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and Metformin in a Diabetic Clinic. Diabetes Care 1983; 6:472–474.
4. Krentz AJ, Ferner RE, Bailey CJ. Comparative Tolerability Profiles of Oral Antidiabetic Agents. Drug Saf 1994; 11:223–241.
5. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of Metformin in Type II Diabetes: Results of a DoubleBlind,
6. Placebo-Controlled, Dose-Response Trial. Am J Med 1997; 103:491–497.
7. Belcher G, Lambert C, Edwards G, Urquhart R, Matthews DR. Safety and Tolerability of Pioglitazone, Metformin, and Gliclazide in the Treatmentof Type2 Diabetes. Diabetes Res Clin Pract 2005; 70:53–62.
8. Sowers JR, Zemel MB. Clinical implications of hypertension in the diabetic patient: A Review. Am J Hypertens 1990; 3:415-424.
9. Okosun IS Chandra KM, Choi S, Cristman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res 2001; 9(1):1-9.
10. Reaven GM, Hoffman BB. Symposium on diabetes and hypertension. Am J Med 1989; 87:1S-42S.
11. Kankanalaa K, Billurb R, Reddy VR, Mukkantia K, Palb S. TFAA-H3PO4 mediated rapid and single-step synthesis of mutual prodrugs of paracetamol and NSAIDs. Green Chem Lett Reviews 2012; 5(3):421-432.
12. Andhale GS, Giles D, Das AK, Bose A, Metikurki B. Design, Synthesis and Chemical Hydrolysis study of codrugs of propranolol with metformin. Eur J Pharma Med Res 2018; 5:395-404.
13. Andhale GS, Giles D, Das AK, Metikurki B, Gurubasavarajaswamy PM. Design, Synthesis and Chemical Hydrolysis study of codrugs of metoprolol with metformin. Inter J Pharma Sci Drug Res 2018; 10:95-102.
14. Baidya M, Das AK. Synthesis and Hydrolytic Kinetic study of some Antihypertensive Co-drugs. Indian J Hetero Chem 2011; 20:343-346.
15. Nielsenw NW, Bundgaard H. Glycolamide esters as biolabile prodrugs of carboxylic acid agents: synthesis, stability, bioconversion, and physicochemical properties. J Pharm Sci 1988; 77:285–298.
16. Alam O, Khan SA, Siddiqui N, Ahsan W, Verma SP, Gilani SJ. Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: Synthesis and pharmacological evaluation. Eur J Med Chem 2010; 45:5113-5119.
17. Bhutani R, Pathak DP, Kaoor G, Husain A, Kant R, Iqbal MA. Synthesis, molecular modeling studies and ADME prediction of benzothiazole clubbed oxadiazole-mannich bases, and evaluation of their anti-diabetic activity through in vivo model. Bioorg Chem 2018; 77:6-15.
18. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46(1-3):3-26.

Published

2018-12-08

How to Cite

Andhale, G. S. (2018). CHEMICAL HYDROLYSIS, INSILICO PHYSICOCHEMICAL PROPERTIES AND IN-VIVO PHARMACOLOGICAL EVALUATION OF ANTIDIABTIC AND ANTIHYPERTENSIVE CODRUGS. Asian Journal of Pharmaceutical Research and Development, 6(6), 36–43. https://doi.org/10.22270/ajprd.v6i6.452

Issue

Vol. 6 No. 6 (2018): VOLUME 6 ISSUE 6 NOV - DEC 2018

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).